Diedrich, US
Andre Diedrich, Nashville, TN US
Patent application number | Description | Published |
---|---|---|
20150313608 | COMPRESSION DEVICE, SYSTEM, AND METHOD FOR DECREASING ABDOMINAL VENOUS POOLING - A compression device can include an adjustable belt, an inflation bladder, and a control module. The adjustable belt can be sized to fit circumferentially around a subject's abdomen. The inflatable bladder and the control module can be secured to the belt. The control module can include a housing that encloses at least one of a pump, a pressure relief valve, and a controller. The pump and the pressure relief valve can be in fluid communication with the bladder. The pump can be configured to inflate the bladder to a pre-determined pressure and apply a compressive pressure to the subject's abdomen. The pressure relief valve can be configured to decrease the pressure within the bladder. The controller can be configured to automatically adjust the compressive pressure in response to a change in the subject's posture. The controller can be in electrical communication with the pump and the pressure relief valve. | 11-05-2015 |
Brad Diedrich, Oregon, WI US
Patent application number | Description | Published |
---|---|---|
20110255711 | Lighting and Audio Communication System - A lighting and communication system with a horn enclosure for recessed ceiling panel or wall mounting, including a speaker with a horn expansion area to direct sound waves from the speaker to a horn enclosure front, at least one light enclosure located within the horn enclosure, the light enclosure defining a light cavity which is separated from said horn expansion area, with a light source inside the light cavity. The light source can be an LED array, which is capable of displaying text, colors or patterns in response to a control system signal. | 10-20-2011 |
20130016864 | Lighting and Audio Communication System - A lighting and communication system with a horn enclosure for recessed ceiling panel or wall mounting, including a speaker with a horn expansion area to direct sound waves from the speaker to a horn enclosure front, at least one light enclosure located within the horn enclosure, the light enclosure defining a light cavity which is separated from said horn expansion area, with a light source inside the light cavity. The light source can be an LED array, which is capable of displaying text, colors or patterns in response to a control system signal. | 01-17-2013 |
Brad Michael Diedrich, Monroe, WI US
Patent application number | Description | Published |
---|---|---|
20080279415 | SPEAKER CONE AND DUST CAP ASSEMBLY - A speaker cone and dust cap assembly for a speaker is disclosed having an acoustic web for a dust cap that has a lower surface with a convex shape; a speaker cone with an end web, sized and arranged to close the first end of the former distal the magnet assembly of the speaker, the end web comprising a concave surface shaped conformally with a central portion of the lower surface of the acoustic web; and having the end surface of the end web fixed to the central portion of the lower surface of the acoustic web over substantially the entire surface of the end surface of the end web. The speaker cone may have a cylindrical extension wrapping the first end of the former. The cylindrical extension and the first end of the former may have aligned vents. | 11-13-2008 |
20080280501 | ADJUSTABLE TERMINAL BLOCK - An adjustable terminal is disclosed having a plurality of electrical contacts electrically coupled between a corresponding number of pair-wise electrically-coupled input terminals and output terminals. A plurality of mechanically coupled jumpers are operable to pair-wise jump the electrical contacts to reconfigure the adjustable terminal variously for bi-amplifier output, parallel output, and series output at said output terminals. A housing is disclosed having support for the electrical contacts and for the jumpers, as well as labels for inputs, outputs, and current configuration. | 11-13-2008 |
Brad Michael Diedrich, Oregon, WI US
Patent application number | Description | Published |
---|---|---|
20120250931 | SHALLOW SPEAKER - An improved shallow speaker is disclosed having a molded diaphragm with an outer, depending, annular cylindrical subcone that connects to a channel formed in the outer perimeter of the spider. Embodiments for round and cornered (polygonal, etc.) speakers are provided. The top plate has a raised outer annular portion for receiving an annular spider flange with or without screw holes for clamping the inner spider flange with a spider ring. In the cornered speaker embodiments, flanges extend from the cylindrical portions to the cornered portions including from a diaphragm inner glue flange over the depressed central portion and from the annular cylindrical subcone both outwardly and inwardly to top diaphragm portions. Routing of the tinsel may be through one or more openings in the annular cylindrical subcone and along the diaphragm inner surfaces, with channels in or on those surfaces for securely routing the tinsel. | 10-04-2012 |
Devin Diedrich, Ramsey, MN US
Patent application number | Description | Published |
---|---|---|
20150148964 | HVAC CONTROLLER WITH PROXIMITY BASED MESSAGE LATENCY CONTROL - Message latency between an HVAC controller located within a building and a remote server may be reduced in response to a determination that a user is in proximity to the HVAC controller, and message latency may be increased when a user is not expected to be proximity to the HVAC controller. This may reduce the overall power consumption of an HVAC controller while still maintaining a good user experience. This can be particularly important for HVAC controllers that are powered by a local energy storage device, such as a battery. | 05-28-2015 |
Gundo Diedrich, Potomac, MD US
Patent application number | Description | Published |
---|---|---|
20100210034 | METHODS OF DETERMINING PATIENT RESPONSE BY MEASUREMENT OF HER-3 - The invention provides methods of measuring and/or quantifying the presence and/or amount of Her-3 and/or Her-3 in a complex in a sample. The invention also provides antibodies specific for Her-3. | 08-19-2010 |
20100233732 | Methods of Determining Patient Response By Measurement of HER-2 Expression - Methods are provided for determining or otherwise assessing the response of a patient to treatment, in particular, to cancer treatment. The methods include the analysis of samples for the presence or the absence of HER2 markers alone or in conjunction with other biomarkers, such as HER3 markers. In certain examples, the probable time to progression can be determined by first determining HER2 positive patients and then further stratifying by using the presence or the absence of a second biomarker (e.g, HER3 markers). In addition, the data can be used to track a patient's response to a treatment regimen, assessing the expected success of treating a patient using a particular regiment, determining the effects of a treatment regiment or for categorizing a patient in order to create a homogenous group for a clinical trial. | 09-16-2010 |
Gundo Diedrich, South San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20100074893 | ECM-Complex Antibody Compositions and Methods of Use - The invention provides isolated anti-ECM-complex antibodies that bind to ECM-complexes. The invention also encompasses compositions comprising an anti-ECM-complex antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-ECM-complex antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-ECM-complex antibodies. The invention encompasses a method of producing the anti-ECM-complex antibodies. Other aspects of the invention are a method of detecting an ECM-complex expressing cancer, a method of inhibiting growth of an ECM-complex-expressing tumor, and a method of alleviating or treating an ECM-complex-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-ECM-complex antibody to the mammal. | 03-25-2010 |
20100136009 | OVR110 Antibody Compositions and Methods of Use - Isolated antibodies and antigen binding fragments thereof directed against Ovrl 10 which is expressed by head and neck, ovarian, endometrial, kidney, pancreatic, lung or breast cancer are provided. Also provided are cells and methods for their production as well as methods for their use in killing an Ovrl 10-expressing cancer cells and alleviating or treating an Ovrl 10-expressing cancer in a mammal. The anti-Ovrl 10 antibodies modulate Ovrl 10 function or internalize upon binding to Ovrl 10 expressed by mammalian cells in vitro and in vivo. Compositions comprising an anti-Ovrl 10 antibody and a carrier as well as articles of manufacture or kits thereof are also provided. In addition, isolated nucleic acids encoding an anti-Ovrl 10 antibody, expression vectors containing the isolated nucleic acids, and host cells containing the vectors are provided. | 06-03-2010 |
20100150907 | PRO115 ANTIBODY COMPOSITIONS AND METHODS OF USE - The invention provides isolated anti-Pro115 antibodies that bind to Pro115. The invention also encompasses compositions comprising an anti-Pro115 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro115 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro115 antibodies. The invention encompasses a method of producing the anti-Pro115 antibodies. Other aspects of the invention are a method of killing an Pro115-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro115 antibody and a method of alleviating or treating an Pro115-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro115 antibody to the mammal. | 06-17-2010 |
20130071859 | Methods of Determining Patient Response by Measurement of HER-3 - The invention provides methods of measuring and/or quantifying the presence and/or amount of Her-3 and/or Her-3 in a complex in a sample. The invention also provides antibodies specific for Her-3. | 03-21-2013 |
20130232589 | OVR110 ANTIBODY COMPOSITIONS AND METHODS OF USE - Isolated antibodies and antigen binding fragments thereof directed against Ovr110 which is expressed by head and neck, ovarian, endometrial, kidney, pancreatic, lung or breast cancer are provided. Also provided are cells and methods for their production as well as methods for their use in killing an Ovr110-expressing cancer cells and alleviating or treating an Ovr110-expressing cancer in a mammal. The anti-Ovr110 antibodies modulate Ovr110 function or internalize upon binding to Ovr110 expressed by mammalian cells in vitro and in vivo. Compositions comprising an anti-Ovr110 antibody and a carrier as well as articles of manufacture or kits thereof are also provided. In addition, isolated nucleic acids encoding an anti-Ovr110 antibody, expression vectors containing the isolated nucleic acids, and host cells containing the vectors are provided. | 09-05-2013 |
20140370523 | Methods of Determining Patient Response by Measurement of HER-2 Expression - Methods are provided for determining or otherwise assessing the response of a patient to treatment, in particular, to cancer treatment. The methods include the analysis of samples for the presence or the absence of HER2 markers alone or in conjunction with other biomarkers, such as HER3 markers. In certain examples, the probable time to progression can be determined by first determining HER2 positive patients and then further stratifying by using the presence or the absence of a second biomarker (e.g, HER3 markers). In addition, the data can be used to track a patient's response to a treatment regimen, assessing the expected success of treating a patient using a particular regiment, determining the effects of a treatment regiment or for categorizing a patient in order to create a homogenous group for a clinical trial. | 12-18-2014 |
20150175701 | OVR110 ANTIBODY COMPOSITIONS AND METHODS OF USE - Isolated antibodies and antigen binding fragments thereof directed against Ovr110 which is expressed by head and neck, ovarian, endometrial, kidney, pancreatic, lung or breast cancer are provided. Also provided are cells and methods for their production as well as methods for their use in killing an Ovr110-expressing cancer cells and alleviating or treating an Ovr110-expressing cancer in a mammal. The anti-Ovr110 antibodies modulate Ovr110 function or internalize upon binding to Ovr110 expressed by mammalian cells in vitro and in vivo. Compositions comprising an anti-Ovr110 antibody and a carrier as well as articles of manufacture or kits thereof are also provided. In addition, isolated nucleic acids encoding an anti-Ovr110 antibody, expression vectors containing the isolated nucleic acids, and host cells containing the vectors are provided. | 06-25-2015 |
Jennifer Ann Diedrich, Kaukauna, WI US
Patent application number | Description | Published |
---|---|---|
20140018762 | Containment Pant - A permanently closed containment pant includes an elastically extensible chassis and a sling positioned within the chassis. The sling is joined to the front waist region and the back waist region. The sling includes a fluid-impervious base sheet and a containment flap joined with the base sheet to create a fluid-impervious pouch. The sling also includes a first transition and a second transition that are elastically extensible in a longitudinal direction and in a transverse direction. Material properties of the pouch and chassis provide the proper fit for comfort and leakage protection. | 01-16-2014 |
Jon Diedrich, Carleton, MI US
Patent application number | Description | Published |
---|---|---|
20100284073 | System and method for mounting a polarizer - A mounted polarizer and corresponding assembly method is provided. The mounted polarizer includes a substrate, and a polarizer with a plurality of parallel wires mounted on a supporting base. An epoxy binds the polarizer to the substrate, such that the plurality of parallel wires is mounted between the substrate and the supporting base, and the epoxy is in direct contact with the plurality of wires. The substrate, the epoxy and the supporting base all have a substantially matching refractive index. The mounted polarizer substantially transmits one polarization of light, and substantially blocks transmission of another polarization of light. | 11-11-2010 |
Nathaniel W. Diedrich, Dublin, OH US
Patent application number | Description | Published |
---|---|---|
20100138690 | System and Method for Managing an On-Board Entertainment System - A system and method for managing an on board entertainment system is disclosed. The system and method can wirelessly receive music files from a computer and store those music files on an on board unit associated with a motor vehicle. The system and method can also include provisions to associate music information with a received music file and can include provisions to manage the music collection on board a motor vehicle. | 06-03-2010 |
20100287138 | MOTOR VEHICLE POWER MANAGEMENT SYSTEM - A power management system for a motor vehicle is disclosed. The power management system can track one or more usage parameters to insure that electrical accessories or resources do not fully drain a battery and leave enough battery life to conduct at least one cold start. In some cases, the power management system can track one or more of the following usage parameters: the amount of time of one or more hands free telephone systems are used, the number of attempts to contact a computer, and/or the amount of time used to conduct wireless communications with a computer that is physically separate from the motor vehicle. | 11-11-2010 |
Tamara R. Diedrich, Duluth, MN US
Patent application number | Description | Published |
---|---|---|
20090117265 | ROAD AND REPAIR MATERIALS INCLUDING MAGNETITE AND METHODS REGARDING SAME - A road and repair system and/or method using one or more components including a plurality of magnetite concentrate particles, at least one acidic activator including phosphate anions, and a plurality of reactive aggregate particles including iron. | 05-07-2009 |